Brief: Senti Biosciences Q1 Net Income USD -12.111 Million
09/05/2024 21:06
May 09 (Reuters) - Senti Biosciences Q1 operating expenses USD 16.301 million. * Q1 operating income USD -16.301 million * Q1 basic EPS USD -0.26 * Q1 EPS USD -0.26
Recent news on Senti Biosciences Holdings
See all newsBrief: Senti Biosciences Says Offering 15.97 Million Shares Of Common Stock For Resale By Selling Securityholder
Senti Biosciences Q1 net loss narrows on cost reduction
Brief: Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy
Brief: Senti Biosciences Announces Holding Company Reorganization Effective By April 16, 2026 - SEC Filing
Senti Biosciences Q4 revenue misses analyst estimates